FindTrial
Sign In

Cost-effectiveness of antifibrosis therapy for idiopathic pulmonary fibrosis: a medical records based study

Cost-effectiveness of antifibrosis therapy for idiopathic pulmonary fibrosis: a multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032105
Enrollment
Unknown
Registered
2020-04-20
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic pulmonary fibrosis

Interventions

Case records:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Confirmed cases of idiopathic pulmonary fibrosis

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
the cost-effectiveness;—

Countries

China

Contacts

Public ContactXiaofan Fei

West China Hospital, Sichuan University

1145342867@qq.com+86 18980601638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026